• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Volpi Kirsten M sold $347,313 worth of shares (10,116 units at $34.33), exercised 6,000 shares at a strike of $9.59 and gifted 3,800 shares, decreasing direct ownership by 11% to 62,396 units (SEC Form 4)

    2/6/25 6:35:51 PM ET
    $TTEK
    Military/Government/Technical
    Consumer Discretionary
    Get the next $TTEK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Volpi Kirsten M

    (Last) (First) (Middle)
    3475 EAST FOOTHILL BOULEVARD

    (Street)
    PASADENA CA 91107

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    TETRA TECH INC [ TTEK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    02/04/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    COMMON STOCK 02/04/2025 S 1,671 D $34.41(1) 68,641 D
    COMMON STOCK 02/04/2025 S 4,100 D $34.326(2) 64,541 D
    COMMON STOCK 02/04/2025 S 4,345 D $34.31(1) 60,196 D
    COMMON STOCK 02/05/2025 M 6,000 A $9.59 66,196 D
    COMMON STOCK 02/05/2025 G 3,800 D $0(3) 62,396 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    STOCK OPTION (RIGHT TO BUY) $9.59(4) 02/05/2025 M 6,000 11/17/2018(5) 11/18/2027 COMMON STOCK 6,000 $9.59 10,000(6) D
    Explanation of Responses:
    1. All shares sold at an exact price.
    2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.32 to $34.33, inclusive.
    3. Bona fide gift. No compensation was given to the donor for the gifting of shares.
    4. On September 6, 2024, the exercise price of $47.95 was updated pursuant to a 5 to 1 forward stock split.
    5. The option becomes exercisable as to 100% of the shares on the anniversary of the grant date.
    6. On September 6, 2024, the balance of 3,200 shares was updated pursuant to a 5 to 1 forward stock split, resulting in an additional 12,800 shares of common stock.
    Remarks:
    /s/ Preston Hopson, Attorney-in-fact for Kirsten M. Volpi 02/06/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TTEK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TTEK

    DatePrice TargetRatingAnalyst
    2/6/2025Buy → Hold
    Maxim Group
    5/16/2024$234.00 → $268.00Buy
    Maxim Group
    5/2/2024$225.00Neutral → Buy
    Northcoast
    1/10/2024$191.00Overweight
    KeyBanc Capital Markets
    9/13/2023Outperform
    William Blair
    8/28/2023$181.00Outperform
    RBC Capital Mkts
    1/17/2023Sector Weight → Overweight
    KeyBanc Capital Markets
    7/15/2022Neutral
    Northcoast
    More analyst ratings